Study guide

1.3 Standard-Setting Organizations & the Manuals They Publish

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

1.3 Standard-Setting Organizations & the Manuals They Publish

Key Takeaways Explain This Topic AI

The Commission on Cancer publishes Optimal Resources for Cancer Care (2020 Standards, updated October 2025) and STORE, the data manual for CoC-accredited hospital registries.

NCI SEER publishes the Solid Tumor Rules, the Hematopoietic and Lymphoid Neoplasm Coding Manual and Database, Summary Stage 2018 and the SEER Program Coding and Staging Manual.

NAACCR maintains the Data Standards and Data Dictionary, the Site-Specific Data Item (SSDI) Manual, the Grade Manual and the EDITS metafiles, and certifies central registries.

CAP cancer protocols define synoptic pathology reporting, and NCCN Clinical Practice Guidelines are the evidence-based treatment guidelines most often cited at cancer conferences.

Each coding question has a governing manual: Solid Tumor Rules for solid-tumor primaries and histology, the Hematopoietic Manual for heme neoplasms, AJCC for TNM, Summary Stage 2018 for Summary Stage, the Grade Manual for grade, and STORE for facility treatment items.

Last updated: September 2026

Why "who publishes what" is tested

Domain 2 names six organizations outright: CAP, CoC, NAACCR, NCCN, NPCR and SEER . Many coding questions are really asking which manual to open. When two manuals seem to disagree, the answer usually comes from knowing which standard setter owns the data item. For example, hospital registries use STORE rules for Class of Case, while central registries in SEER areas use the SEER manual for SEER-specific items.

  • The organizations
  • National Cancer Registrars Association (NCRA)

The professional association for cancer registrars. Its Council on Certification , an elected certification board created in 2002, runs the ODS exam and credential maintenance. NCRA also publishes the Cancer Registry Management: Principles & Practice textbook (4th edition), the Journal of Registry Management and the Professional Practice Code of Ethics , and it accredits formal cancer registry education programs.

Commission on Cancer (CoC) of the American College of Surgeons

A consortium of more than 50 national professional organizations, founded in 1922, that accredits about 1,500 cancer programs in the U.S. and Puerto Rico. Its main publications are:

Optimal Resources for Cancer Care (2020 Standards) , effective January 2020 and updated October 2025: the accreditation standards, such as Standard 2.1 (cancer committee), 4.3 (registry staff credentials), 6.1 (registry quality control) and 6.5 (follow-up).

Standards for Oncology Registry Entry (STORE) : the data dictionary and coding rules that CoC-accredited registries must follow, including case eligibility, Class of Case, treatment items and follow-up. STORE replaced FORDS for 2018 diagnoses; the NCRA exam references STORE 2025.

National Cancer Database (NCDB) , run jointly with the American Cancer Society, including the Rapid Cancer Reporting System (RCRS) .

NCI Surveillance, Epidemiology, and End Results (SEER) Program

The National Cancer Institute's population-based surveillance program, collecting data since 1973 and now covering about 48% of the U.S. population. SEER publishes:

The SEER Program Coding and Staging Manual (reportability and coding rules for SEER registries).

The Solid Tumor Rules (multiple primary and histology rules for solid tumors).

The Hematopoietic and Lymphoid Neoplasm Coding Manual and the Hematopoietic Database (Heme DB).

Summary Stage 2018 and Extent of Disease (EOD) 2018.

SEER*Rx , the interactive drug database used to classify drugs as chemotherapy, hormone therapy, immunotherapy or ancillary.

CDC National Program of Cancer Registries (NPCR)

Created by the Cancer Registries Amendment Act of 1992 (Public Law 102-515) . NPCR funds and sets data standards for central registries in 46 states, the District of Columbia, Puerto Rico, the U.S. Pacific Island jurisdictions and the U.S. Virgin Islands. NPCR and SEER together cover the entire U.S. population and jointly publish U.S. Cancer Statistics .

North American Association of Central Cancer Registries (NAACCR)

The consensus body for data standards across U.S. and Canadian central registries. Standard setters such as CoC, SEER, NPCR and the Canadian Council of Cancer Registries agree on changes through NAACCR. NAACCR maintains:

Standards for Cancer Registries, Volume II: Data Standards and Data Dictionary (item numbers, lengths and codes) and the NAACCR XML exchange format.

The Site-Specific Data Item (SSDI) Manual and the Grade Manual (Grade Coding Instructions and Tables v3.2 is an open-book reference for 2026).

The EDITS metafiles that registry software runs to validate data.

Registry certification (Gold and Silver) for central registries.

American Joint Committee on Cancer (AJCC)

Publishes the TNM staging system. The 8th edition took effect for 2018 diagnoses. AJCC now updates individual sites as Version 9 protocols; cervix, appendix, anus and lung (effective with 2025 diagnoses) are examples. The 2026 open-book PDFs contain AJCC 8th edition Parts XI (Breast), XIII (Male Genital Organs) and XIV (Urinary Tract) plus Lung Version 9.

College of American Pathologists (CAP)

Publishes the CAP Cancer Protocols , the templates that define the required "core elements" of a synoptic pathology report. CoC Standard 5.1 requires that at least 90% of eligible cancer pathology reports use CAP synoptic format (see Chapter 10).

National Comprehensive Cancer Network (NCCN)

An alliance of leading cancer centers that publishes the NCCN Clinical Practice Guidelines in Oncology , with evidence-and-consensus categories 1, 2A, 2B and 3. Registrars use these guidelines when preparing cancer conference cases, monitoring concordance studies and judging whether expected treatment was given.

World Health Organization (WHO) and IARC

Publish the International Classification of Diseases for Oncology, Third Edition, Second Revision (ICD-O-3.2) and the WHO Classification of Tumours ("Blue Books"). The Solid Tumor Rules and the Hematopoietic Database are built on the Blue Books. NAACCR issues annual ICD-O histology and behavior updates that registries apply alongside ICD-O-3.2.

Which manual governs which decision

Decision Governing reference Open-book in 2026?

Is this tumor reportable? STORE (CoC-accredited programs), SEER manual (SEER registries), state rules and ambiguous-term lists No

One primary or more; which histology code (solid tumors) Solid Tumor Rules Yes

One primary or more; histology and primary site (leukemia, lymphoma, myeloma) Hematopoietic Manual and Heme DB No

Topography and morphology codes ICD-O-3.2 plus NAACCR updates and the Solid Tumor Rules tables Solid Tumor Rules tables only

  • TNM categories and stage group AJCC Cancer Staging System Yes (Breast, Male Genital, Urinary Tract, Lung V9)
  • Summary Stage Summary Stage 2018 v3.3 Yes
  • Grade Clinical, Pathological, and Post Therapy (yc, yp) Grade Manual v3.2 Yes
  • Surgery of primary site code STORE Appendix A Yes
  • Radiation phase items STORE Radiation chapter Yes
  • Class of Case, dates, chemotherapy and other treatment items STORE No
  • Drug category SEER*Rx No
  • Accreditation requirements Optimal Resources for Cancer Care No
  • Using the open-book PDFs efficiently

Identify the governing manual before you search. A question about "how many abstracts" belongs in the Solid Tumor Rules; a question about "which T category" belongs in an AJCC chapter.

Use bookmarks first, then search. Every open-book PDF has embedded bookmarks. Jump to the site module or chapter, then search inside it for a specific term such as "Paget" or "seminal vesicle."

Follow the hierarchy inside each manual. The Solid Tumor Rules must be applied in order: use the first rule that applies and stop. The Summary Stage and AJCC chapters also have general rules that come before the site-specific tables.

Loading diagram... Standard setters and the data they govern